Mersana Therapeutics Total Liabilities

Mersana Therapeutics (MRSN) currently reports a total liabilities of $120M as of September 2025. That compares with $170M in the prior-year period — down 27.5% year over year. Use the charts on this page to explore Mersana Therapeutics's total liabilities history and peer comparisons.

Mersana Therapeutics's total liabilities decreased from $170M to $120M — a 27.5% year-over-year decrease (period ending September 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Mersana Therapeutics reported $120M in total liabilities as of September 2025. That compares with $170M in the prior-year period — down 27.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $120M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Mersana Therapeutics, and consider following MRSN for alerts when major investors trade the stock.

Mersana Therapeutics is classified in the Healthcare sector. On total liabilities, it currently shows $120M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing MRSN with unrelated industries.